Operating Cash Flow
Bristol-Myers Squibb Operating Cash Flow decreased by 44.1% to $1.10B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 43.5%, from $1.95B to $1.10B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -3.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Consistently high operating cash flow indicates a healthy, self-sustaining business capable of funding its own growth and returning capital to shareholders.
Detailed definition
Net cash from operating activities measures the total amount of cash generated by a company's core business operations....
Peer comparison
Investors often compare this to capital expenditures to calculate Free Cash Flow, a primary valuation metric for mature tech giants.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.06B | $5.27B | $4.06B | $3.81B | $2.26B | $3.69B | $3.31B | $2.97B | $1.89B | $4.75B | $4.25B | $2.83B | $2.33B | $5.59B | $4.44B | $1.95B | $3.92B | $6.31B | $1.97B | $1.10B |
| QoQ Change | — | +72.1% | -23.0% | -6.0% | -40.7% | +63.1% | -10.3% | -10.2% | -36.5% | +151.8% | -10.5% | -33.3% | -17.9% | +140.4% | -20.6% | -56.0% | +100.5% | +61.1% | -68.7% | -44.1% |
| YoY Change | — | — | — | — | -26.1% | -30.0% | -18.5% | -22.1% | -16.5% | +28.9% | +28.6% | -4.6% | +23.3% | +17.7% | +4.4% | -31.1% | +68.4% | +12.9% | -55.5% | -43.5% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's operating cash flow?
- Bristol-Myers Squibb (BMY) reported operating cash flow of $1.10B in Q1 2026.
- How has Bristol-Myers Squibb's operating cash flow changed year-over-year?
- Bristol-Myers Squibb's operating cash flow decreased by 43.5% year-over-year, from $1.95B to $1.10B.
- What is the long-term trend for Bristol-Myers Squibb's operating cash flow?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's operating cash flow has grown at a -3.3% compound annual growth rate (CAGR), from $16.21B to $14.16B.
- What does operating cash flow mean?
- The actual amount of cash a company brings in from its day-to-day business activities.